URMC Research Network

Find People
Last Name
More Search Options

Chad Heatwole

TitleAssociate Professor
InstitutionSchool of Medicine and Dentistry
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 673
Rochester NY 14642
 Awards And Honors
      Patient and Family Centered Care Award  | University of Rochester
2012 - 2014Myotonic Dystrophy Foundation Research Grant (Supervising Mentor for Dr. Nick Johnson)  | Myotonic Dystrophy Foundation
2011 - 2015FDA Research Grant: Mexiletine Treatment in Myotonic Dystrophy Type-1 (Co-Investigator)  | FDA
2010 - 2012NIH Clinical Research Loan REpayment Grant REnewal Recipient  | NIH
      Strong Star Award for Exceptional Service and Displaying Compassion and Respect to Patients, Familes and Co-workers
1997     Awarded Virginia Tech's Best ESM 1997 Ind. Senior Project Presentation
2006 - 2008NIH Clinical Research Loan Repayment Grant Recipient  | NIH
2006 - 2007NIH Experimental Therapeutics Grant Recipient for  | NIH
      Dean's List (General Engineering, and in ESM)
      Tau Beta Pi National Engineering Honor Society
2007     NIH Clinical and Translational Science Institute K12 Award Recipient  | NIH
      Board of Supervisors Academic Excellence Award
2003     UCB Pharma, Inc. Neurology Resident Scholar
1998 - 1999S.O.M. State Discretionary Scholarship Winner 1998, 1999
      Awarded Virginia Tech's Best ESM Ind. Senior Project Presentation 1997  | Virginia Tech
      Tau Beta Pi National Engineering Honor Society
2005     Ad Hoc editor for Neurology
2010     Clinical Research Loan Repayment Grant Renewal Recipient  | NIH
2003     UCB Pharma, Inc. Neurology Resident Scholar. 2003
1998 - 1999S.O.M. State Discretionary Scholarship Winner
2008     Clinical Research Loan Repayment Grant Renewal Recipient  | NIH
1999     Student Elective Term Scholarship Winner (MMA) 1999
2008     Paul Wellstone Muscular Dystrophy Cooperative Research Center Umbrella Center  | MDCRC
      Student Elective Term Scholarship Winner (MMA) 1999
      Dean's List (General Engineering, and in ESM)
2008 - 2013NIH K23 Career Development Grant Award Winner (NIAMS)  | NIH
2008 - 2010NIH Clinical Research Loan Repayment Grant Recipient  | NIH
2004     American Neurology Association Scholarship Winner, Toronto 2004  | American Neurology Association
      Board of Supervisors Academic Excellence Award
      American Neurology Association Scholarship Winner 2004
2008 - 2010ECRIP (Empire Clinical Research Investigator Program) Grant Award Winner (
      Patient and Family-Centered Care award (2011)
      Golden Key Member
      Golden Key Member
2008 - 20112008 Muscular Dystrophy Association Translational Research Infrastructure Grant Award Winner (Funding from 2008-2011)
Chad Heatwole, MD, MS-CI is a neuromuscular clinician and researcher from the University of Rochester. He has an engineering degree from Virginia Tech, a medical degree from the Medical College of Virginia, a master's degree in clinical investigation, and has completed a University of Rochester neurology residency, electrophysiology fellowship, and NIH-funded neuromuscular experimental therapeutics fellowship. His research funding has included a National Institute of Arthritis and Musculoskeletal and Skin Diseases K23 award, a Muscular Dystrophy Association TRIG award, and a New York State ECRIP award (among other awards). Dr. Heatwole's research has led to the development of an international network dedicated to improving the quality-of-life of neuromuscular patients through patient-centered clinical research. His primary professional interests include providing optimal care to patients with neuromuscular disorders, performing electrodiagnostic studies, training medical personnel, evaluating novel experimental therapeutics for neurological diseases though clinical trials, and developing an improved infrastructure to utilize disease-specific, patient-relevant endpoint measures for use in clinical trials and patient monitoring.

 Selected Publications
List All   |   Timeline
  1. Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, Mcdermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R. Myotonic Dystrophy Health Index: Initial evaluation of a disease-specific outcome measure. Muscle Nerve. 2014 Jun; 49(6):906-14.
    View in: PubMed
  2. Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson MS, Moxley RT, Thornton CA. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2013 Dec; 74(6):862-72.
    View in: PubMed
  3. Johnson NE, Heatwole CR, Ferguson M, Sowden JE, Jeanat S, Herrmann DN. Patient Identification of the Symptomatic Impact of Charcot-Marie-Tooth Disease Type 1A. J Clin Neuromuscul Dis. 2013 Sep; 15(1):19-23.
    View in: PubMed
  4. Johnson NE, Heatwole CR. Teaching Video NeuroImages: Trapezius myotonia percussion sign in myotonic dystrophy type 2. Neurology. 2013 Jun 11; 80(24):e251.
    View in: PubMed
  5. Heatwole CR, Statland JM, Logigian EL. The diagnosis and treatment of myotonic disorders. Muscle Nerve. 2013 May; 47(5):632-48.
    View in: PubMed
  6. Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2013 Apr; 23(4):306-12.
    View in: PubMed
  7. Johnson NE, Quinn C, Eastwood E, Tawil R, Heatwole CR. Patient-identified disease burden in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2012 Dec; 46(6):948-50.
    View in: PubMed
  8. Johnson NE, Heatwole CR. Myotonic dystrophy: from bench to bedside. Semin Neurol. 2012 Jul; 32(3):246-54.
    View in: PubMed
  9. Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012 Jul 24; 79(4):348-57.
    View in: PubMed
  10. Heatwole C, Johnson N, Holloway R, Noyes K. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
    View in: PubMed
  11. Heatwole C, Johnson N, Goldberg B, Martens W, Moxley R. Laboratory abnormalities in patients with myotonic dystrophy type 2. Arch Neurol. 2011 Sep; 68(9):1180-4.
    View in: PubMed
  12. Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1. Arch Neurol. 2011 Jan; 68(1):37-44.
    View in: PubMed
  13. Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT. Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1. Muscle Nerve. 2010 Feb; 41(2):191-6.
    View in: PubMed
  14. Heatwole C, Ciafaloni E. Mycophenolate mofetil for myasthenia gravis: a clear and present controversy. Neuropsychiatr Dis Treat. 2008 Dec; 4(6):1203-9.
    View in: PubMed
  15. Heatwole C. International Education Issues: practicing and teaching international neurology: the Krakow experience. Neurology. 2007 Oct 23; 69(17):1721-3.
    View in: PubMed
  16. Heatwole CR, Moxley RT. The nondystrophic myotonias. Neurotherapeutics. 2007 Apr; 4(2):238-51.
    View in: PubMed
  17. Heatwole CR, Miller J, Martens B, Moxley RT. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol. 2006 Aug; 63(8):1149-53.
    View in: PubMed
  18. Heatwole CR, Berg MJ, Henry JC, Hallman JL. Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis. Neurology. 2005 Mar 22; 64(6):1096-7.
    View in: PubMed


Heatwole's Networks

Similar People
Same Department